Used as a key intermediate in the synthesis of antiviral and antidiabetic pharmaceuticals. It serves as a chiral building block in drug development, particularly in the production of sitagliptin, a medication for type 2 diabetes. Its structure allows for selective binding and improved metabolic stability in active pharmaceutical ingredients. Also employed in the preparation of enzyme inhibitors due to its ability to mimic transition states in peptide hydrolysis.